Delivery Order SPE2DB22D2206-SPE2DB23FFN12
Award Date 2/3/23
Potential Completion Date 2/27/23
Potential Value $108K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 100 capsules of the pharmaceutical Revlimid 10 mg, with a potential value of $213,074.21. The delivery order is part of a larger indefinite delivery contract with DLA Troop Support Medical for Amerisourcebergen to provide pharmaceuticals and medical supplies to support military treatment...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The order, valued at $27,859.78, is for the supply of 28-count capsules of the pharmaceutical Revlimid 10 mg. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is one of multiple awards to Amerisourcebergen Drug Corp under an Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $51,681.12 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action issued under...
- The Defense Logistics Agency awarded a $19.2K delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for the supply of Revlimid 10 mg capsules in quantities of 28 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 29, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,466.84 to AmerisourceBergen Drug Corp for the supply of Revlimid 15 mg capsules (21-count packaging) on January 28, 2026. This firm fixed-price contract is non-competitive and represents a single delivery order with an ultimate completion date of February 19, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance and serves as the prime contractor. The company is a subsidiary of...
- The Defense Logistics Agency awarded a $12,329.16 delivery order to AmerisourceBergen Drug Corp for 28 capsules of Revlimid 5 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a firm fixed price of $178,310.12 and a period of performance through August 8, 2024. The award is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for delivering a wide range...
- The Defense Logistics Agency awarded a delivery order valued at $7,233.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 25 mg capsules (21-count) on January 23, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by February 13, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency awarded a $27,425.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 2.5 mg capsules (28-count units), with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $19,176.36 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on January 23, 2026, with a completion date of February 13, 2026. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contractor's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp is a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FFN12Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 100 capsules of the pharmaceutical product Revlimid 10 mg, with a potential value of $107,912.38. The delivery order has a completion date of February 27, 2023 and was awarded on February 3, 2023. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp is a for-profit organization providing pharmaceutical products and distribution services to support DLA Troop Support Medical programs and facilities.
Generated 3/23/24, 5:02 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $107.9k | 2/3/23 |